NCT02868749 is a NA clinical trial of Hyaluronic Acid filler in Atrophy, sponsored by Vandeputte, Joan, M.D..

Who is sponsoring NCT02868749?

NCT02868749 is sponsored by Vandeputte, Joan, M.D..

What drugs are being tested in NCT02868749?

Interventions in NCT02868749: Hyaluronic Acid filler, Hyaluronic Acid filler.

Is NCT02868749 still recruiting?

NCT02868749 is currently completed. Last updated 23 January 2019.

Last reviewed 2019-01-23 · How we verify

NCT02868749

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue

Completed NA Last updated 23 January 2019

What this trial tests

NA trial testing Hyaluronic Acid filler in Atrophy in 5 participants. Completed in 30 September 2018.

Timeline

22 March 2017

Primary endpoint
11 April 2018

30 September 2018

Quick facts

Lead sponsor	Vandeputte, Joan, M.D.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	single
Primary purpose	basic science
Enrollment	5
Start date	22 March 2017
Primary completion	11 April 2018
Estimated completion	30 September 2018
Sites	2 locations across Belgium

Drugs / interventions tested

Hyaluronic Acid filler
Hyaluronic Acid filler

Conditions studied

Atrophy — all drugs for Atrophy →

Sponsor

Vandeputte, Joan, M.D.

Who can join

Adults 18 to 70, any sex, with Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a single-blind intra-individual comparative study to evaluate the short and medium term tissue response after the injection of 2 brands of hyaluronic acid gels (HA), designed for deep injection, that have been used for several years on a worldwide scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atrophy

Currently open trials in the same condition.

NCT05698316 — A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Predicti · active not recruiting
NCT05626855 — Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab · Phase 3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02868749 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vandeputte, Joan, M.D.
Last refreshed: 23 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02868749.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing